Document is current
Any future updates will be listed below
-
Authors
Peters, Jim
Penning de Vries, Bas B. L.
van Dijck, Jos A.A.M.
Mann, Ritse M.
Moriakov, Nikita
Teuwen, Jonas
Karssemeijer, Nico
Lips, Esther H.
Wesseling, Jelle
van Leeuwen, Merle M.
van den Belt-Dusebout, Alexandra W.
van Gils, Carla H.
Pijnappel, Ruud
de Munck, Linda
van Oirsouw, Marja
Verschuur, Ellen
Elias, Sjoerd G.
Broeders, Mireille J. M.
-
Funding
Funding for this research was provided by:
Dutch Cancer Society (11835)
Dutch Cancer Society (11835)
Dutch Cancer Society (11835)
Dutch Cancer Society (11835)
Dutch Cancer Society (11835)
Dutch Cancer Society (11835)
Dutch Cancer Society (11835)
Dutch Research Council (5550004201)
Dutch Research Council (5550004201)
- License Information
-
More Information
Article History
Received: 17 September 2025
Accepted: 26 March 2026
First Online: 20 April 2026
Competing interests
: The authors declare the following relationships: M.B. received grants from ScreenPoint Medical, Sectra Benelux, Hologic, Volpara Solutions, Lunit, and iCAD and received speaker fees and travel support from Hologic and Siemens HealthCare. N.K. is board member and shareholder of ScreenPoint Medical and shareholder of Volpara Technology. R.M. received research grants or equipment from Bayer, Siemens, ScreenPoint Medical, Koning, Becton Dickinson, PA Imaging and Lunit and provided consultancy for ScreenPoint Medical, Becton Dickinson, Bayer, Guerbet, Bracco and Siemens. J.T. is Associate Editor of npj breast cancer. J.T. was not involved in the journal’s review of, or decisions related to, this manuscript. The other authors do not have a competing interest.
